| Literature DB >> 32099825 |
Piyawut Kreetapirom1, Potjanee Kiewngam1, Wanlapa Jotikasthira1, Wasu Kamchaisatian1, Suwat Benjaponpitak1, Wiparat Manuyakorn1.
Abstract
BACKGROUND: A reliable objective tool using as a predictor of asthma control status could assist asthma management.Entities:
Keywords: Asthma; Frequency of resonance; Reactance; Resistance; Spirometry
Year: 2020 PMID: 32099825 PMCID: PMC7016320 DOI: 10.5415/apallergy.2020.10.e3
Source DB: PubMed Journal: Asia Pac Allergy ISSN: 2233-8276
Baseline characteristics
| Variable | C-C group (n = 41) | C-LC group (n = 27) | ||
|---|---|---|---|---|
| Sex | 0.74 | |||
| Male | 26 (63.4) | 19 (70.4) | ||
| Female | 15 (36.6) | 8 (29.6) | ||
| Age (yr) | 9.93 ± 1.85 | 8.93 ± 2.0 | 0.04 | |
| Height (cm) | 137.07 ± 13.44 | 128.37 ± 13.45 | 0.01 | |
| Weight (kg) | 37.59 ± 13.99 | 31.78 ± 13.81 | 0.10 | |
| Aeroallergen sensitization | 31 (75.6) | 22 (81.5) | 0.79 | |
| Allergic rhinitis | 3 (85.4) | 22 (81.5) | 0.81 | |
| Tobacco exposure | 8 (19.5) | 5 (18.5) | 0.08 | |
| Age of asthma diagnosis (yr) | 5.83 ± 2.71 | 4.96 ± 2.02 | 0.16 | |
| Duration of asthma (yr) | 3.86 ± 2.13 | 3.71 ± 1.99 | 0.77 | |
| Inhaled corticosteroid dosage (µg)* | 218.79 ± 185.15 | 203 ± 140.72 | 0.95 | |
Values are presented as number (%) or mean ± standard deviation.
C-C group, group of children who maintained their level of asthma well-controlled; C-LC group, group of children who lost their level of asthma well-controlled at the end of the study.
*Beclomethasone equivalent dose/day.
Comparison forced oscillation technique measures between C-C and C-LC groups
| Variable | C-C group | C-LC group | ||
|---|---|---|---|---|
| Prebronchodilator | ||||
| R5 (cmH2O/L/sec) | 6.98 ± 2.11 | 9.98 ± 2.42 | <0.001 | |
| R5 (% predicted) | 89.28 ± 18.44 | 114.91 ± 23.39 | <0.001 | |
| R20 (cmH2O/L/sec) | 5.83 ± 1.52 | 7.82 ± 1.61 | <0.001 | |
| R20 (% predicted) | 118.84 ± 38.85 | 126.56 ± 34.27 | 0.405 | |
| X5 (cmH2O/L/sec) | −0.63 ± 0.47 | −0.93 ± 0.61 | 0.03 | |
| X5 (% predicted) | 27.95 ± 21.70 | 27.46 ± 20.53 | 0.9 | |
| ALX | 2.54 ± 2.22 | 4.19 ± 4.04 | 0.03 | |
| Bronchodilator response | ||||
| ∆R5 (%) | 12.92 ± 10.48 | 30.28 ± 11.32 | <0.001 | |
| ∆R20 (%) | 13.96 ± 10.4 | 24.65 ± 11.52 | <0.001 | |
| ∆ALX (%) | 14.58 ± 62.45 | 26.43 ± 64.4 | 0.45 | |
Values are presented as mean ± standard deviation.
C-C group, group of children who maintained their level of asthma well-controlled; C-LC group, group of children who lost their level of asthma well-controlled at the end of the study.
R5, resistance at 5 Hz; R20, respiratory resistance at 20 Hz; X5, respiratory reactance at 5 Hz; ALX, area of reactance; ∆, percentage of bronchodilator response.
Comparison spirometric measures between C-C and C-LC groups
| Variable | C-C group | C-LC group | ||
|---|---|---|---|---|
| Prebronchodilator | ||||
| FVC (% predicted) | 92.5 ± 10.0 | 98.7 ± 16.6 | 0.06 | |
| FEV1 (% predicted) | 89.7 ± 13.3 | 96 ± 19.4 | 0.11 | |
| FEV1/FVC (%) | 88.5 ± 6.6 | 87.6 ± 5.5 | 0.58 | |
| FEF25%–75% (% predicted) | 95 ± 29.3 | 92.3 ± 29.3 | 0.71 | |
| Bronchodilator response | ||||
| ∆FVC (%) | 1.3 ± 5.9 | 4.3 ± 4.5 | 0.03 | |
| ∆FEV1 (%) | 3.7 ± 5.9 | 7.9 ± 5.4 | 0.004 | |
| ∆FEV1/FVC (%) | 2.4 ± 3.4 | 3.5 ± 3.4 | 0.18 | |
| ∆FEF25%–75% (%) | 15.1 ± 15.4 | 23.3 ± 15.9 | 0.04 | |
Values are presented as mean ± standard deviation.
C-C group, group of children who maintained their level of asthma well-controlled; C-LC group, group of children who lost their level of asthma well-controlled at the end of the study.
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; FEF25%-75%, forced expiratory flow 25%–75%; ∆, percentage of bronchodilator response.
Logistic regression to predict loss of asthma control
| Predictor variable | Regression coefficient | AUC (95% CI) | |
|---|---|---|---|
| R5 (% predicted) | 0.059 | 0.810 (0.700–0.920) | <0.001 |
| R5 (% predicted) | 0.049 | 0.859 (0.770–0.950) | <0.001 |
| ∆R5 (%) | 0.069 | - | - |
| ∆FEV1 (%) | 0.278 | 0.910 (0.840–0.980) | <0.001 |
| R5 (% predicted) | 0.044 | - | - |
| ∆R5 (%) | 0.124 | - | - |
| FEV1 (% predicted) | 0.059 | 0.924 (0.860–0.990) | <0.001 |
| ∆FEV1 (%) | 0.302 | - | - |
| R5 (% predicted) | 0.045 | - | - |
| ∆R5 (%) | 0.144 | - | - |
AUC, area under the curve; CI, confidence interval; R5, resistance at 5 Hz; FEV1, forced expiratory volume in 1 second.
Cutoff points in predicting of loss of asthma symptom control on a follow-up visit
| Variable | Cutoff points | AUC (95% CI) | Sensitivity | Specificity | ||
|---|---|---|---|---|---|---|
| FOT parameters | ||||||
| R5 (% predicted) | 91.28 | 0.812 (0.702–0.922) | 0.821 | 0.56 | <0.001 | |
| R20 (% predicted) | 122.23 | 0.55 (0.41–0.69) | 0.59 | 0.52 | 0.48 | |
| X5 (% predicted) | 21.16 | 0.47 (0.33–0.61) | 0.48 | 0.44 | 0.72 | |
| Spirometric parameters | ||||||
| FVC (% predicted) | 96.4 | 0.60 (0.44–0.75) | 0.52 | 0.66 | 0.176 | |
| FEV1 (% predicted) | 89.5 | 0.54 (0.387–0.699) | 0.52 | 0.52 | 0.55 | |
| FEV1/FVC (%) | 88.99 | 0.43 (0.29–0.57) | 0.52 | 0.44 | 0.32 | |
| FEF25%–75% (% predicted) | 91.65 | 0.46 (0.32–0.60) | 0.48 | 0.59 | 0.57 | |
| Postbronchodilator response | ||||||
| ∆R5 (%) | 21.2 | 0.79 (0.68–0.90) | 0.70 | 0.70 | <0.001 | |
| ∆R20 (%) | 24.8 | 0.74 (0.62–0.86) | 0.52 | 0.90 | <0.001 | |
| ∆FVC (%) | 2.75 | 0.67 (0.54–0.80) | 0.70 | 0.59 | 0.018 | |
| ∆FEV1 (%) | 7.8 | 0.69 (0.57–0.81) | 0.52 | 0.76 | 0.008 | |
| ∆FEV1/FVC (%) | 3 | 0.59 (0.45–0.72) | 0.52 | 0.63 | 0.21 | |
| ∆FEF25%–75% (%) | 15.2 | 0.65 (0.52–0.79) | 0.70 | 0.57 | 0.035 | |
FOT, forced oscillation technique; AUC, area under the curve; CI, confidence interval; R5, resistance at 5 Hz; R20, respiratory resistance at 20 Hz; X5, respiratory reactance at 5 Hz; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; FEF25%-75%, forced expiratory flow 25%–75%; ∆, percentage of bronchodilator response.